On Jun. 16, 2021, Moderna announced that the U.S. government had purchased an additional 200 million doses of…
On Jun. 16, 2021, Pfizer and The Academic Research Organization (ARO) from the Hospital Israelita Albert Einstein announced…
On Jun. 16, 2021, Moderna announced that the U.S. government had purchased an additional 200 million doses of…
On Jun. 15, 2021, Moderna and Magenta Investments, an industrial conglomerate in the United Arab Emirates (UAE), announced…
On Jun. 14, 2021, Kaiser Permanente Washington Health Research Institute (KPWHRI) announced that was recruiting volunteers in the…
On Jun. 14, 2021, University of British Columbia researchers Dr. Jayachandran Kizhakkedathu, Dr. Caigan Du and Dr. Christopher…
On Jun. 14, 2021, Moderna announced that it had submitted an authorization application to Swissmedic for use of…
On Jun. 14, 2021, Novavax announced that NVX-CoV2373, its recombinant nanoparticle protein-based COVID-19 vaccine, demonstrated 100% protection against…
On Jun. 14, 2021, Novavax announced data from the first co-administration study of a SARS-CoV-2 vaccine candidate [Novavax,…
On Jun. 13, 2021, in a landmark agreement at G7 summit, held in Cornwall, UK, global leaders have…
On Jun. 11, 2021, Moderna and and Tabuk Pharmaceutical Manufacturing Company (a fully owned subsidiary of Astra Industrial…
On Jun. 11, 2021, The U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for…
On Jun. 11, 2021, Novavax announced preclinical and clinical data on the company’s original recombinant protein COVID-19 vaccine…
On Jun. 10, 2021, Moderna announced that it had requested an emergency use authorization (EUA) for its COVID-19…
On Jun. 10, 2021, Pfizer and BioNTech announced plans to provide the U.S. government at a not-for-profit price…
On Jun. 8, 2021, Twist Bioscience announced that it has started shipping its synthetic RNA reference controls for…
On Jun. 8, 2021, Inovio Pharma announced an expansion of its previously announced partnership with Advaccine Biopharmaceuticals to…
On Jun. 7, 2021, Moderna announced a new agreement to commercialize its COVID-19 Vaccine across Central Eastern Europe…
On Jun. 7, 2021, Moderna announced announced that it had submitted for a variation to the conditional marketing…
On Jun. 4, 2021, The U.S. Food and Drug Administration (FDA) approved Chimerix’s Tembexa (brincidofovir) tablets and oral…
On Jun. 3, 2021, Moder’s vaccine against COVID-19, to support the government’s ongoing efforts to secure access to…
On Jun. 2, 2021, Lonza announced the expansion of its collaboration with Moderna. The expanded collaboration extended the…
On Jun. 2, 2021, UNICEF announced it had signed a long-term agreement with Moderna for the supply of COVID-19 vaccine on behalf of the…
On Jun. 2, 2021, Vaxxas announced that research demonstrated the potential of Vaxxas’ novel high-density microarray patch (HD-MAP)…
On Jun. 1, 2021, the National Institutes of Health (NIH) announced the first-in-human, Phase 1 trial assessing the…
On Jun. 1, 2021, World Health Organization (WHO) validated the Sinovac-CoronaVac COVID-19 vaccine for emergency use, giving countries,…
On Jun. 1, 2021, the heads of the world’s predominant global financing, health and trade agencies united to…
On Jun. 1, 2021, the National Institutes of Health (NIH) announced that it had started a Phase 1/2…
On Jun. 1, 2021, Moderna announced that it had initiated the rolling submission process with the U.S. Food…
On Jun. 1, 2021, the U.S. Department of Health and Human Services (HHS) unveiled a new type of…